Patents by Inventor Stefan J. Kirchanski

Stefan J. Kirchanski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5098849
    Abstract: A material and method are described to reduce the non-specific binding of a labelled material, wherein the labelled material comprises a fluorochrome and a specific binding pair member. The invention is particularlly suited to the lysis of peripheral blood wherein a labelled material is used to identify and detect cell populations within a sample of blood.
    Type: Grant
    Filed: July 13, 1988
    Date of Patent: March 24, 1992
    Assignee: Becton Dickinson and Company
    Inventors: Fred J. Hilerio, Stefan J. Kirchanski
  • Patent number: 5053054
    Abstract: Reagents and methods for intracellular staining of anionic materials as provided. The inherent staining characteristics of a fluorescent molecule may be suitably altered by covalently linking a plurality of said molecules to a nonimmunoglobulin derived cationic polymer having the desired staining specificity. By careful selection of the net charge and size of the dye polymer complex, diffusion through the cellular membrane can be enhanced and an enhanced fluorescent signal obtained by localization of a plurality of fluorescent molecules at the site of interest.
    Type: Grant
    Filed: September 14, 1989
    Date of Patent: October 1, 1991
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Stefan J. Kirchanski, A. R. M. Azad, Peter J. Natale
  • Patent number: 4882284
    Abstract: A method is provided for discriminating white blood cells from red blood cells and platelets in an unlysed, whole blood sample. The white blood cells may be discriminated into five subpopulations: lymphocytes, monocytes, neutrophils, eosinophils and basophils. A red light absorbing fluorescent dye is utilized along with a measurement system comprised of a red light source and suitable detectors for red fluorescence, forward light scatter and right angle scatter.
    Type: Grant
    Filed: April 13, 1987
    Date of Patent: November 21, 1989
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Stefan J. Kirchanski, Kathleen Wardwell
  • Patent number: 4637986
    Abstract: Lysing reagents for use in flow cytometry instruments. Lysing reagents suitable for lysing red blood cells are provided thereby permitting 3-part differential counting of white blood cells. The reagents comprise a leukoprotective agent for preserving the lymphocyte cellular integrity during analysis, and buffers adjusted to provide the correct pH environment for optimal lysis and activity. Preferred embodiments will additionally incorporate non-ionic preservatives in very low concentrations.
    Type: Grant
    Filed: August 22, 1983
    Date of Patent: January 20, 1987
    Assignee: Ortho Diagnostic Systems, Inc.
    Inventors: Michael C. Brown, Stefan J. Kirchanski
  • Patent number: 4581334
    Abstract: Methods for the determination of phagocytic and killing ability of selected leukocyte subclasses based upon the use of three part differentials obtained by light scatter characteristics and gated fluorescence. Particles having multiple fluorescent labels associated therewith, one of which is sensitive to reactive oxygen, incubated with the leukocytes. Detection of the fluorescent labels permits identification of cells having phagocytic ability, as determined by presence of the non-sensitive label, and also the identification of those with killing ability as determined by the decrease in fluorescence from the sensitive label.
    Type: Grant
    Filed: April 25, 1983
    Date of Patent: April 8, 1986
    Assignee: Ortho Diagnostics Systems, Inc.
    Inventors: Stefan J. Kirchanski, Giora Davidovits, Robert A. Hoffman
  • Patent number: 4434150
    Abstract: An immunological substance detecting reagent is provided which, in the preferred embodiment, employs an immunological homolog specific for the immunological substance to be detected coupled to a water-soluble polymer having a net charge not greater than zero. The water-soluble polymer further has associated a plurality of marker substances such as fluorophore molecules thereby providing a reagent of increased sensitivity for the detection of an antigen-antibody immunological reaction.
    Type: Grant
    Filed: October 19, 1981
    Date of Patent: February 28, 1984
    Assignee: Ortho Diagnostic Systems, Inc.
    Inventors: A. R. M. Azad, Stefan J. Kirchanski, Michael C. Brown